BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.
about
BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions.Biomarker in Colorectal Cancer.Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern.Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015.Molecular markers of prognosis and therapeutic targets in metastatic colorectal cancer.The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases.Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.Validation of clinical risk scores for laparoscopic liver resections of colorectal liver metastases: A 10-year observed follow-up study.The role of autophagy in hepatocellular carcinoma: friend or foe.Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience.BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives.Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all-RAS.The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.RAS Mutation Is Associated with Decreased Survival in Patients Undergoing Repeat Hepatectomy for Colorectal Liver Metastases.Reply to the letter to the editor 'new life for retrospective study in the precision oncology era' by Orlandi et al.Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
P2860
Q35685684-BAFB3FEF-0307-4EFD-9C19-E84E4A3201C7Q37061363-3E1E22B1-113E-4373-B258-84E24E195E78Q37086263-48BD6359-C73D-4291-BAF9-70012EE98311Q37114675-2F641614-1801-493C-93FC-3AF65F7DB5C4Q37525272-08B4865B-F7C2-441F-8D3D-B30956DB694FQ38787278-944A8B33-0031-438A-86DF-2D68B7524C0AQ38938329-C222CB80-FA73-49FE-923A-927D38E4ECC8Q39238657-6FE33A23-6E33-4EF7-A8C8-C52C8E84C844Q39626850-A41457D3-E719-4EF3-AA04-A4553C9E90AFQ39708324-904F8F67-B061-4E16-96DB-D3E0BF4891F7Q39722702-5F194762-1190-4B1F-8B5A-097125061A4DQ40510578-2BD2FE3E-11AC-4CB2-B7E6-FD8472FCCDA7Q41339988-766ED3DF-06D3-40A0-8CD7-D92F84CE311CQ47640854-CD0BD664-3042-44C8-B959-32FD4D298F82Q47767987-8D3569DA-763C-48A2-B957-AC28F80FF4DDQ47784299-271891AC-552C-4CF6-8EB5-A6C02FF049F7Q48136626-6B7EA2B9-2A6D-4593-89EF-B0C8CD33E294Q48197461-D57D6467-BE1A-4F88-BD19-B09471690DD9Q49580510-ADC0280B-A12A-46BF-937A-99659BC3128AQ52982174-A5499224-6B6F-4BB6-BB26-36AFE9DF037FQ54247867-131B3B96-EBEE-4280-B185-4501C7C9F927Q56969146-FE234B83-22A1-46F7-8671-7F8A3AFF1AAC
P2860
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
BRAF and RAS mutations as prog ...... ts undergoing liver resection.
@ast
BRAF and RAS mutations as prog ...... ts undergoing liver resection.
@en
type
label
BRAF and RAS mutations as prog ...... ts undergoing liver resection.
@ast
BRAF and RAS mutations as prog ...... ts undergoing liver resection.
@en
prefLabel
BRAF and RAS mutations as prog ...... ts undergoing liver resection.
@ast
BRAF and RAS mutations as prog ...... ts undergoing liver resection.
@en
P2093
P2860
P50
P356
P1476
BRAF and RAS mutations as prog ...... nts undergoing liver resection
@en
P2093
F Marmorino
G De Maglio
G Pasquini
M Casagrande
P2860
P2888
P304
P356
10.1038/BJC.2015.142
P407
P50
P577
2015-05-05T00:00:00Z